A Randomized, Double-Blind, Placebo-Controlled, Polysomnography Plus Outpatient Study to Determine the Safety and Efficacy of 4 mg Ramelteon in Adults With Chronic Insomnia.
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2013
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 21 Mar 2012 This trial is recruting in England, Finland and France.
- 21 Mar 2012 Planned patient number is 1200 according to European Clinical Trials Database.
- 21 Mar 2012 Additional locations (Austria, England, Finland, France, Germany) added as reported by European Clinical Trials Database.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History